FDA.reportPublic FDA data

niraparib 100 MG (as niraparib tosylate monohydrate 159.3 MG) Oral Tablet

RxCUI
2637449
RxNorm name
niraparib 100 MG (as niraparib tosylate monohydrate 159.3 MG) Oral Tablet
Display name
niraparib 100 MG (as niraparib tosylate monohydrate 159.3 MG) Oral Tablet
Full name
niraparib 100 MG (as niraparib tosylate monohydrate 159.3 MG) Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:17

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ZEJULANIRAPARIBGlaxoSmithKline LLCb7f675e2-159c-490c-b6f4-3f16d9492b7d2026-07-28Warnings, Adverse reactionsExact identifier
rxcui: 2637449

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b7f675e2-159c-490c-b6f4-3f16d9492b7dniraparib 100 MG Oral Tablet [PSN] · niraparib 100 MG Oral Tablet [SCD] · niraparib 100 MG (as niraparib tosylate monohydrate 159.3 MG) Oral Tablet [SY]39These highlights do not include all the information needed to use ZEJULA safely and effectively. See full prescribing information for ZEJULA. ZEJULA (niraparib) tablets, for oral use Initial U.S. Approval: 201720260327